| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/ANNONC/MDQ573 |
| P698 | PubMed publication ID | 21059639 |
| P50 | author | Piero Picci | Q40240179 |
| Lorenza Gandola | Q40521827 | ||
| Roberto Luksch | Q44065943 | ||
| Franca Fagioli | Q56926311 | ||
| Kirsten Sundby Hall | Q60655545 | ||
| P2093 | author name string | S Ferrari | |
| G Bacci | |||
| E Barbieri | |||
| M Carli | |||
| M Mercuri | |||
| R Capanna | |||
| A Prete | |||
| A Tamburini | |||
| A Tienghi | |||
| M Alberghini | |||
| A Brach Del Prever | |||
| T A Alvegard | |||
| S Mapelli | |||
| T Wiebe | |||
| S Smeland | |||
| P2860 | cites work | Ewing's sarcoma family of tumors: current management | Q28242009 |
| Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study) | Q28366229 | ||
| Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study. | Q37198992 | ||
| Predictive factors of histologic response to primary chemotherapy in patients with Ewing sarcoma. | Q40448095 | ||
| Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant. | Q40471939 | ||
| High-dose busulphan/melphalan with autologous stem cell rescue in Ewing's sarcoma. | Q42545990 | ||
| Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone | Q44320806 | ||
| Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992. | Q44700959 | ||
| Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients | Q46359097 | ||
| Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies. | Q50886149 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| chemotherapy | Q974135 | ||
| P304 | page(s) | 1221-1227 | |
| P577 | publication date | 2010-11-08 | |
| P1433 | published in | Annals of Oncology | Q326122 |
| P1476 | title | Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol | |
| P478 | volume | 22 |
| Q38627336 | Advantages in Prognosis of Adult Patients with Ewing Sarcoma: 11-years Experiences and Current Treatment Management. |
| Q35103838 | An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas. |
| Q36701492 | Askin tumor: A rare neoplasm of thoracopulmonary region |
| Q33274572 | Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up |
| Q57570627 | Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up |
| Q37718471 | CD99 polymorphisms significantly influence the probability to develop Ewing sarcoma in earlier age and patient disease progression |
| Q33410703 | Chemotherapy-related toxicity in patients with non-metastatic Ewing sarcoma: influence of sex and age. |
| Q37048919 | Clinical outcomes and prognostic factors of adult's Ewing sarcoma family of tumors: single center experience |
| Q36327466 | Congenital Ewing's Sarcoma/Primitive Neuroectodermal Tumor of the Upper Extremity |
| Q53167841 | Consolidation of first-line therapy with busulphan and melphalan, and autologous stem cell rescue in children with Ewing's sarcoma. |
| Q45876267 | Cord blood hematopoietic stem cell transplantation in an adolescent with haemophilia |
| Q64113037 | Ewing Sarcoma in Nepal Treated With Combined Chemotherapy and Definitive Radiotherapy |
| Q56609038 | Ewing sarcoma |
| Q34575191 | Ewing sarcoma of the bone in children under 6 years of age |
| Q60933303 | Ewing sarcoma of the mobile spine; predictive factors for survival, neurological function and local control. A Scandinavian sarcoma group study with a mean follow-up of 12 years |
| Q37937915 | Ewing sarcoma treatment |
| Q37980482 | Ewing sarcoma: clinical state-of-the-art |
| Q50894700 | Ewing's sarcoma family of tumors in Finland during 1990-2009: a population-based study. |
| Q92825455 | Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation |
| Q90279795 | High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008 |
| Q58760461 | High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008 |
| Q37285696 | High-dose chemotherapy and autologous peripheral blood stem cell transplantation in the treatment of children and adolescents with Ewing sarcoma family of tumors |
| Q35821531 | Impressive Response to Dose-Dense Chemotherapy in a Patient with NUT Midline Carcinoma. |
| Q53687227 | Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Influences Sensitivity to Anti-IGF System Agents Through the Translational Regulation of IGF1R. |
| Q33403469 | Interval compressed vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide, etoposide in patients with advanced Ewing's and other Small Round Cell Sarcomas |
| Q38778855 | Investigational therapies for Ewing sarcoma: a search without a clear finding |
| Q39084808 | Is There Benefit to Free Over Pedicled Vascularized Grafts in Augmenting Tibial Intercalary Allograft Constructs? |
| Q34636631 | Late effects of chemotherapy and radiotherapy in osteosarcoma and Ewing sarcoma patients: the Italian Sarcoma Group Experience (1983-2006). |
| Q28073218 | Management of Ewing sarcoma family of tumors: Current scenario and unmet need |
| Q26740437 | Multimodality Treatment in Ewing's Sarcoma Family Tumors of the Maxilla and Maxillary Sinus: Review of the Literature |
| Q41924654 | Noncoding RNA in drug resistant sarcoma |
| Q99710967 | Outcome of multidisciplinary treatment of peripheral primitive neuroectodermal tumor |
| Q41587144 | Post-relapse survival in patients with Ewing sarcoma |
| Q35110009 | Primary Ewing's Sarcoma of the Kidney in a 73-Year-Old Man |
| Q45969231 | Prognostic factors and clinical outcome of patients with Ewing's sarcoma family of tumors in adults: multicentric study of the Anatolian Society of Medical Oncology. |
| Q50658268 | Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression. |
| Q40414026 | Referral patterns, treatment and outcome of high-grade malignant bone sarcoma in Scandinavia--SSG Central Register 25 years' experience |
| Q36891003 | Retrospective clinicopathological study of malignant bone tumors in children and adolescents in Romania - single center experience |
| Q55426535 | Role of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation for Children and Young Adults with Relapsed Ewing's Sarcoma: A Systematic Review. |
| Q48239404 | Sinusoidal obstruction syndrome/veno-occlusive disease after high-dose intravenous busulfan/melphalan conditioning therapy in high-risk Ewing Sarcoma. |
| Q38315670 | The indications and efficacy of conventional chemotherapy in primary and recurrent sarcoma |
| Q37560522 | The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas |
| Q43833260 | The value of high-dose chemotherapy in patients with first relapsed Ewing sarcoma |
| Q26752425 | UK guidelines for the management of bone sarcomas |
| Q35958189 | Vaginal metastasis of a Ewing Sarcoma five years after resection of the primary tumor |
| Q33805175 | What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group - EWING1 |
| Q39465507 | miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy |
Search more.